← Back to Search

Other

BTL-785-7 Treatment for Wrinkles

N/A
Waitlist Available
Research Sponsored by BTL Industries Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a special device that treats facial wrinkles without surgery. It targets people who want to reduce their wrinkles without undergoing invasive procedures. The device works by using energy to tighten the skin and boost collagen production. These methods have been reported to be safe and effective for the non-invasive treatment of wrinkles and overall facial rejuvenation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Skin Wrinkling
Secondary study objectives
Evaluation of skin quality and aesthetic changes of the treated areas after the therapies
Subject Satisfaction
Therapy Comfort

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: BTL-785-7 TreatmentExperimental Treatment1 Intervention
Treatment with the BTL-785-7 applicator to the BTL-785F system.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7 Treatment
2022
N/A
~20

Find a Location

Who is running the clinical trial?

BTL Industries Ltd.Lead Sponsor
52 Previous Clinical Trials
1,810 Total Patients Enrolled
13 Trials studying Wrinkles
385 Patients Enrolled for Wrinkles
~6 spots leftby Nov 2025